Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects

• Váldodahkkit: Rita Humeniuk (Dahkki), Anita Mathias (Dahkki), Huyen Cao (Dahkki), Anu Osinusi (Dahkki), Gong Shen (Dahkki), Estelle Chng (Dahkki), John Ling (Dahkki), Amanda Vu (Dahkki), Polina German (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2020-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Remdesivir (RDV), a single diastereomeric monophosphoramidate prodrug that inhibits viral RNA polymerases, has potent in vitro antiviral activity against severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2). RDV received the US Food and Drug Administration (FDA)'s emergency use authoriz...